Andrew R. Miksztal, Ph.D.
Vice President, Pharmaceutical Research and Development, Principal Scientist
Andrew R. Miksztal, Ph.D., joined DURECT in 2000. He has more than 30 years of experience in preformulation, drug substance, and drug product development. Prior to joining DURECT, Dr. Miksztal worked at Syntex Research, Roche Bioscience, and Oread Laboratories. Dr. Miksztal earned his doctorate in bioinorganic chemistry from Rutgers University, and completed a National Institutes of Health (NIH) postdoctoral research fellowship in the chemistry department at the University of California, San Diego. He has numerous scientific publications and is an inventor on many U.S. and foreign patents.